ArticleOncotarget2017

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.

Ion Cristóbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.